Gennev vs JoinJosie for Personalized Care Plans

Many women in perimenopause and menopause are weighing whether Josie or Gennev offers the right match for a single, provider-reviewed care plan that covers both HRT and weight management. The choice matters because one path bundles hormone therapy with compounded GLP-1 options and a weight-maintenance microdose protocol, while the other does not.

By the final section you will know the exact differences in provider oversight, medication options, and maintenance plans that separate the two services, plus a direct answer on which approach fits women seeking one platform for both hormone and weight needs.

Quick Verdict: Josie vs Gennev for Personalized Care Plans

Josie delivers provider-led care that integrates HRT and compounded GLP-1 weight management in a single subscription model, while Gennev focuses primarily on virtual menopause consultations.

Josie offers HRT from $89/mo, GLP-1 weight management from $194/mo, and microdose maintenance from $189/mo. All treatment plans undergo review by licensed providers before any prescription is issued. This structured approach ensures each care plan aligns with individual health needs.

Gennev's pricing and medication offerings are not specified here. The platform centers on virtual consultations for menopause symptoms, yet the scope of ongoing medication management remains less defined.

Josie has written over 5,000 prescriptions for members seeking personalized menopause care. This volume reflects consistent provider oversight and a proven process for matching treatments to patient profiles.

Josie maintains a no auto-billing policy, allowing members to cancel anytime. This flexibility supports women who need adjustments in their care plans without unexpected charges.

Josie members lose an average of 10-12% body weight with semaglutide or 12-15% with tirzepatide in the first 6 months based on self-reported data from approximately 1,500 members. These outcomes highlight the impact of combining medication with provider-guided plans.

Ranked #1 Menopause GLP-1 Provider by Global Women Connected, Josie combines hormone therapy with weight management under one model. This integration supports women navigating perimenopause and menopause with coordinated treatment options.

At a glance: how Josie compares to Gennev, JoinJosie for Personalized Care Plans on the features that matter most.

What Is Josie?

Josie is a provider-led telehealth service combining HRT, GLP-1 weight management, and weight maintenance into one care path for women experiencing perimenopause and menopause. The platform focuses on midlife care that has often been underserved. Every care path receives review from a licensed provider before any treatment begins.

Medications ship from licensed U.S. pharmacies. Provider licenses cover all 50 states. This structure supports consistent access to care regardless of location.

Current enrollment exceeds 5,000 members. Care remains personalized to individual perimenopause and menopause symptoms. The approach integrates hormone replacement therapy with weight management under unified provider oversight.

What Is Gennev?

Gennev operates as a telehealth platform offering virtual consultations and menopause care coordination, though exact service scope and medication options vary.

The platform connects women with healthcare providers who focus on menopause symptoms and hormone therapy. Patients access care through scheduled video visits rather than traditional office appointments.

Telehealth services allow patients to discuss symptoms, review treatment options, and coordinate follow-up care from home. Providers may recommend lifestyle changes alongside medication management when appropriate.

Care coordination includes helping patients connect with specialists and track progress over time. This model appeals to women seeking convenient access to menopause care without requiring in-person visits.

Service availability and provider networks can differ by location. Some patients may find that appointment availability varies based on demand and geographic coverage.

What Is JoinJosie for Personalized Care Plans?

JoinJosie provides personalized care plans by pairing each patient with a licensed provider who reviews symptoms, labs, and goals before prescribing HRT or GLP-1 therapies. Every prescription undergoes this provider review to match treatment with individual needs.

Care paths are customized specifically to perimenopause and menopause concerns. Provider-led telehealth care paths address both hormone replacement therapy and weight management through GLP-1 medications such as Compounded Semaglutide Injection, Ozempic, Wegovy, and Zepbound.

Patients can cancel anytime without penalty, which provides flexibility when health needs change. Over 5,000 prescriptions have already been written under this model, showing its established use in women's health care.

The process begins with online intake and continues through licensed provider review. Medication ships from a licensed pharmacy when prescribed, with ongoing provider support available for check-ins and dose adjustments.

Weight Management options include full-dose GLP-1 care with both compounded and brand-name medications. Weight Maintenance offers microdose GLP-1 longevity protocols for patients who need lower maintenance dosing after reaching their goals.

Features Compared

Three core features differentiate the platforms across provider oversight, medication types, and maintenance protocols.

These distinctions matter for women seeking menopause care and weight management through telehealth. Each platform approaches personalized care plans differently.

Provider credentials, medication sourcing, and long-term support structures show the clearest contrasts between Gennev and JoinJosie. Understanding these differences helps patients select the right fit for their health needs.

Provider-Led Personalized HRT and Weight Management

Josie assigns every patient a board-certified provider who evaluates hormone levels, metabolic markers, and lifestyle factors before prescribing a combined HRT and GLP-1 regimen.

Dr. Ana Lisa Carr, MD, MBA serves as Medical Director and oversees all clinical protocols. Each plan requires provider review before any prescription reaches the patient.

Ongoing dose titration relies on patient-reported outcomes and scheduled follow-ups. Board certification and multi-state licensing ensure consistent care standards across all fifty states.

Gennev maintains general provider oversight for hormone therapy. JoinJosie incorporates additional metabolic assessment before GLP-1 prescribing decisions.

Both platforms emphasize virtual consultations as the primary care delivery method. The depth of metabolic marker evaluation varies between the two approaches.

Compounded GLP-1 Options for Perimenopause and Menopause

Josie offers four compounded GLP-1 formulations, semaglutide injection, semaglutide ODT, tirzepatide injection, and tirzepatide ODT, each paired with HRT when clinically appropriate.

Compounded GLP-1 medications are not FDA-approved. The FDA does not review compounded medications for safety, effectiveness, or quality before marketing.

Josie does not manufacture compounded medications. Dosages receive customization through scheduled provider follow-ups and patient-submitted symptom logs.

Gennev focuses primarily on FDA-approved hormone therapy options. JoinJosie may offer some branded GLP-1 medications through traditional pharmacy channels.

Patients seeking compounded formulations for cost or dosing flexibility find more options through Josie. Both platforms require regular monitoring for any GLP-1 therapy.

Weight Maintenance Microdose Protocol

After reaching goal weight, Josie transitions patients to a microdose GLP-1 protocol priced at $189/mo to sustain results without full-dose costs.

The microdose plan includes ongoing provider oversight, quarterly labs, and lifestyle coaching to prevent rebound weight gain common in menopause.

94% of Josie members who reach their goal switch to the Microdose Maintenance Plan. This approach addresses the specific challenge of weight maintenance during hormonal transitions.

Gennev offers general wellness programs for ongoing support after initial treatment. JoinJosie provides standard follow-up care without a dedicated microdose structure.

The subscription model at $189/mo removes full-dose medication costs while maintaining clinical supervision. Quarterly labs help detect any metabolic changes that require protocol adjustments.

Pricing Compared

Josie lists transparent monthly fees: HRT starts at $89, GLP-1 weight management at $194, and branded Ozempic, Wegovy, Zepbound at $1,199-$1,299. These rates reflect a subscription model that includes virtual consultations, medication management, and ongoing care coordination.

Gennev pricing is not covered here. When comparing personalized care plans, readers should review each provider's published rates directly. Women seeking menopause care or weight management benefit from clear cost structures that support long-term adherence.

Weight Management (GLP-1) runs as low as $194 per month. Weight Maintenance (Microdose GLP-1) is $189 monthly. HRT starts as low as $89 per month. Branded options include Ozempic as low as $1299 per month, Wegovy as low as $1199 per month, and Zepbound as low as $1099 per month.

Discounts via Find My Path quiz reach up to $100 off the first purchase for Weight Management, $50 off for Weight Maintenance, and $75 off for HRT. No auto-billing, cancel anytime, and no membership or hidden fees apply.

Josie maintains predictable costs through its subscription model. This approach supports treatment personalization for hormone therapy and chronic condition management without unexpected charges. Patients can focus on health outcomes rather than tracking variable expenses.

Who Should Choose Josie

Women seeking an integrated plan that pairs HRT with GLP-1 weight management under one provider team should consider Josie. This approach works well for individuals who want care coordination across hormone therapy and weight management.

Josie serves more than 5,000 members who receive support through a provider-led model. The service ships medication to all 50 states plus internationally, which removes geographic barriers for many women.

The platform focuses on women in perimenopause and menopause who need hormone replacement therapy, weight management, or weight maintenance support. A single care team oversees both the hormone and weight treatment components.

Virtual consultations replace in-person visits for many patients. This format allows women to discuss symptoms, review treatment options, and adjust plans without clinic travel.

Gennev and JoinJosie may offer similar services, yet the scope of medication shipping and the single-provider model for combined treatments differ between platforms. Josie maintains its provider-led structure across all locations it serves.

Women who prefer one team to manage multiple aspects of menopause care often find the coordinated approach beneficial. The ability to receive prescriptions regardless of location makes treatment access more consistent.

Who Should Choose Gennev

Patients looking for a standalone menopause telehealth service without integrated weight-management prescriptions may prefer Gennev. This option appeals to women who want focused care for hormone-related symptoms and prefer to handle other health needs through separate providers.

Gennev operates as a virtual menopause care provider that emphasizes hormone therapy and symptom management. Their model suits individuals who already have established relationships with primary care physicians for other aspects of their health.

Women seeking a dedicated platform for menopause-specific concerns may find this approach straightforward. The service focuses on hormone therapy and related treatments without expanding into comprehensive wellness programs or lifestyle interventions.

Some patients appreciate the simplicity of working with a specialized menopause practice. They can receive virtual consultations and medication management centered specifically on their menopausal symptoms rather than broader health coordination.

Research suggests that focused care models work well for patients who prefer clear boundaries between different health services. Gennev fits this preference by concentrating on one clinical area rather than attempting to address multiple aspects of women's health through a single platform.

Who Should Choose JoinJosie for Personalized Care Plans

Women who want dose personalization, provider review of every prescription, and the option to cancel anytime qualify for JoinJosie's model.

Personalized care plans address perimenopause and menopause symptoms directly. Licensed providers review each prescription before it ships, which reduces the risk of mismatched dosing. This approach appeals to women who have tried generic treatment plans that overlook individual hormone fluctuations.

Medication management follows strict quality standards. Batch-tested medications undergo checks for potency, sterility, pH, and endotoxins. Members receive prescriptions through U.S. certified pharmacies with fast and free shipping included.

The service has issued more than 5,000 prescriptions since launch. Over 5,000 members currently use the platform. Provider-led care means every prescription receives professional review, which builds confidence in the treatment path.

No auto-billing applies to the subscription model. Members can cancel anytime without penalty. This structure works well for women who want flexibility while maintaining access to ongoing menopause care.

Treatment personalization relies on health assessments that guide care paths. The platform focuses exclusively on perimenopause and menopause concerns, which sets it apart from broader telehealth services that may not specialize in these life stages.

Women seeking consistent provider oversight and tailored dosing find the JoinJosie framework aligns with their needs. The combination of licensed review, batch-tested medications, and flexible subscription terms creates a practical option for those managing menopause symptoms.

Final Verdict

Josie stands out for combining HRT and GLP-1 weight management under a single provider-led subscription that can start as low as $89/mo.

With more than 5,000 members and prescriptions filled, Josie has served women seeking coordinated care across multiple conditions. The platform offers personalized care plans that address both menopause symptoms and weight management through one clinical team.

Unlike systems that lock patients into recurring charges, Josie avoids auto-billing. Members control their payments and can adjust or pause service based on their evolving needs.

Medication orders ship from U.S. pharmacies to locations worldwide. This global reach makes Josie accessible for women who travel often or live outside the country.

Gennev operates in a similar telehealth space, though its current focus centers on menopause care without integrated weight management programs. Josie's broader care model may appeal to women managing multiple symptoms at once.

Both platforms rely on virtual consultations and evidence-based protocols. Josie differentiates itself through the dual focus on hormone therapy and GLP-1 medications within a single subscription.

Patients ready to explore these options can reach the Josie team at [email protected] for personalized guidance on next steps.